Physician profile
Eric Hick
NPI 1346236353
$5,416.39
in general payments reported to CMS, 2019-2025
30 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $213 · 2021: $600 · 2022: $463 · 2023: $2,854 · 2024: $417 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813 · Travel and Lodging: $1,479 · Education: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,812.97 |
| Travel and Lodging | $1,479.42 |
| Education | $235.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,466.40 | 2023-2025 | Urolift |
| Boston Scientific Corporation | $921.27 | 2019-2024 | Ams 700, Rezum Generator |
| Astellas Pharma US INC | $779.13 | 2019-2024 | Xtandi, Myrbetriq |
| Medtronic, INC. | $515.43 | 2021-2023 | Interstim |
| Verathon INC. | $400.00 | 2021 | |
| Medtronic USA, INC. | $197.61 | 2019 | |
| Neotract INC. | $141.77 | 2019 | |
| Sumitomo Pharma America, INC. | $132.55 | 2023-2025 | Gemtesa, Orgovyx |
| Intuitive Surgical, INC. | $121.70 | 2022-2023 | Da Vinci Surgical System |
| Dendreon Pharmaceuticals LLC | $89.16 | 2023 | Provenge |
| Laborie Medical Technologies Corp. | $66.20 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $59.00 | 2023 | Lynparza, Keytruda, Welireg |
| Rochester Medical Corporation | $58.74 | 2021-2022 | |
| Janssen Biotech, INC. | $47.97 | 2023 | Erleada |
| Progenics Pharmaceuticals, INC. | $46.05 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $44.12 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $40.19 | 2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Calyxo, INC. | $31.96 | 2023 | Cvac Aspiration System |
| Halozyme INC | $26.54 | 2023 | |
| Tolmar, INC. | $25.61 | 2025 | Jatenzo |
| Agiliti Surgical, INC. | $24.89 | 2023 | Trinity, Sonablate |
| C. R. Bard, INC. & Subsidiaries | $23.08 | 2023 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $22.99 | 2025 | |
| Edap Technomed INC | $22.79 | 2025 | |
| Angiodynamics, INC. | $17.72 | 2023 | Nanoknife |
| Immunitybio, INC. | $17.14 | 2025 | |
| Verity Pharmaceuticals INC. | $15.83 | 2024 | Trelstar |
| Pfizer INC. | $12.99 | 2023 | |
| Srs Medical Systems, INC. | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.